Bioarctics alzheimersbehandling får godkänt i Kina

Dagens Industri · 9 Jan 09:42

Bioarctics behandling mot alzheimers har nu fått godkännande i Kina, uppger bolaget i ett pressmeddelande. Aktien stiger på beskedet.

Lär mer hos Dagens Industri

Analyser, tips och guider får du gratis i Börsen för allas Nyhetsbrev

Language 1

Language 2

Language 3

Privacy on this site

We collect and process your data on this site to better understand how it is used. You can give your consent to all or selected purposes, or you can decline them all. For more information, see our privacy policy.

Analytics

AnalyticsWe'll collect information about your visit to our site. It helps us understand how the site is used – what's working, what might be broken and what we should improve.

NYHET

Bioarctics alzheimersbehandling får godkänt i Kina

Bioarctics alzheimersbehandling får godkänt i Kina